Table 1.
Total number and percentage change of pathologic specimens received, malignant lesions, positivity rate, and predicted missed cases
| Total | Colorectal | Lung | Breast | Prostate | |
|---|---|---|---|---|---|
| Pathologic specimens received | |||||
| 2017 | 528,916 | 57,481 | 91,885 | 19,031 | 8747 |
| 2018 | 535,896 | 59,507 | 95,405 | 19,322 | 8516 |
| 2019 | 552,820 | 62,754 | 106,001 | 19,139 | 9229 |
| 2020 | 455,453 | 48,955 | 87,497 | 18,756 | 7149 |
| % change | –15.53 | –18.29 | –10.5 | –2.13 | –19.04 |
| Malignant lesions | |||||
| 2017 | 41,736 | 6136 | 7046 | 4101 | 1953 |
| 2018 | 42,002 | 6050 | 7120 | 3980 | 1959 |
| 2019 | 43,653 | 5987 | 7736 | 4035 | 2202 |
| 2020 | 41,550 | 5410 | 7802 | 4057 | 1939 |
| 2020 predicted | 44,071.51 | 6011.58 | 8045.98 | 4029.43 | 2416 |
| % change | –5.7 | –10.0 | –3.0 | 0.7 | –19.7 |
| 2020 missed cancer diagnosis | 2521.51 | 601.58 | 243.98 | N/A | 477 |
| Positivity rate | |||||
| 2020 | 9.12 | 11.05 | 8.92 | 21.63 | 27.12 |
| 2020 predicted | 7.84 | 9.23 | 7.34 | 21.04 | 25.44 |
| % change | 16.3 | 19.7 | 21.5 | 2.8 | 6.6 |
Abbreviation: N/A = not applicable.
The percentage change of pathologic specimens received and positivity rate was based on the prior 3-year average. The percentage change of malignant lesions and predicted missed cases was based on the predicted number using a time-series model.